Skip to content
Search

Latest Stories

NICE appoints two new directors to key new positions

The National Institute for Health and Care Excellence (NICE) has announced the appointment of two new directors to key positions in newly formed directorates.

Jennifer Howells has been appointed as director of finance, strategy and transformation and Dr Felix Greaves will serve as the director of science, evidence and analytics.


Both will start serving the agency from September 1.

Howells is currently working for Deloitte as an independent healthcare consultant. She has 16 years of experience in the NHS, most recently as a regional director for NHS England and Improvement after working as regional finance director for NHS England.

Howells also has experience as a chief executive and as finance director for several commissioning and provider trusts.

She will work as the chief finance officer for NICE, taking over from Catherine Wilkinson, acting director and succeeding Ben Bennet, who left the NICE earlier this year after 13 years in the post.

Greaves was appointed in March to the new role of director of science, evidence and analytics.

He is currently working as the deputy director of science and strategic information and the head of science and engineering at the Public Health England.

With 16 years’ experience in the health service, he has worked as a senior clinical lecturer and a registrar, as well as clinical advisor to the Chief Medical Officer and governor of an NHS foundation trust.

Prof Gillian Leng, NICE chief executive, said: “We’re looking forward to implementing changes and developing a new strategy at NICE, and the knowledge and skills that Jennifer and Felix will bring are important in maintaining our position as a global leader in health technology evaluation.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less